 lifelong treatment designed to
eliminate or modify known risk factors for atherosclerosis to
reduce the risk of cardiovascular complications or death. In
addition, treatment of risk factors can reduce the risk of periprocedural complications or death after any invasive treatments undertaken for PAD and may improve the patency of
interventions. Many of the recommendations for risk-factor
modiÔ¨Åcation in PAD have been extrapolated from the literature on secondary prevention in coronary artery disease.
This represents a notable